Immune checkpoint inhibitors (ICIs) have shown significant promise in treating tumors. Immune checkpoint inhibitors are a form of immunotherapy, which redirects and activates the immune system. While ...
The impact of metformin on progression-free survival following immune checkpoint inhibitors in overweight (n = 284 ... tumor ...
Cancer immunotherapy has revolutionized the treatment landscape for various malignancies, offering new hope for patients. However, recent evidence has highlighted significant sex disparities in the ...
Immunotherapies have become a cornerstone in cancer treatment, with current therapies like checkpoint inhibitors enhancing ...
New treatments and adverse events impacting patient quality of life were among the topics of interest in 2024.
Another checkpoint inhibitor has entered the fray, as Checkpoint Therapeutics has passed the FDA’s checkpoint with its PD-L1 inhibitor cosibelimab. The FDA has approved cosibelimab under the brand ...
A deep learning radiomic biomarker has been developed and validated to predict responses to immune checkpoint inhibitors in ...
Medpage Today on MSN4d
Mixed Signals From Trials of Perioperative, Neoadjuvant Immunotherapy for Early TNBCThe results, reported at the San Antonio Breast Cancer Symposium (SABCS), added to the history of mixed messages from trials ...
Patients with heavily pretreated microsatellite stable metastatic colorectal cancer (CRC) had survival benefits after using ...
TuHURA Biosciences, Inc. (Nasdaq: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies ...
Patients with early breast cancer who are older may experience high-grade immune-related side effects after receiving immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback